Kestra Medical Technologies, Ltd. (KMTS) SEC Filings & Earnings Calls

Continued Operating Losses

“We incurred net losses of $44.1 million and $25.8 million for the three months ended July 31, 2026 and 2025, respectively.” · word for word

Dependence on Third-Party Payors

“We derive nearly all our revenue from the direct billing of various third-party payors, including Medicare, Medicaid, private payors and other healthcare-related organizations, for the lease of our ASSURE® WCD to patients.” · word for word

Negative Operating Cash Flow

“For the three months ended July 31, 2026 and 2025, we generated negative operating cash flows of $32.3 million and $26.3 million, respectively.” · word for word

Net loss and adjusted EBITDA loss widened despite revenue growth, indicating high operating expenses and investment spending.

“GAAP net loss of $44.1M vs $25.8M; adjusted EBITDA loss of $24.0M vs $19.4M.”

Debt service and covenant risk from $200M credit facility

“Loan agreement includes variable interest rate (SOFR + 5.50% with 3.25% floor), minimum liquidity of $20M, and customary covenants.”

Dependence on WCD market expansion and reimbursement

“Revenue growth driven by WCD market expansion and in-network patient mix; changes in reimbursement could impact growth.”

Limited operating history and profitability uncertainty

“We have a limited operating history, which may make it difficult for you to evaluate our current business and its likelihood of success and viability.” · word for word

Dependence on single product (ASSURE WCD) and reimbursement

“We generate revenue primarily by leasing our ASSURE WCD as part of our Cardiac Recovery System platform, and we are therefore highly dependent on our ASSURE WCD for our continued success.” · word for word

Reimbursement rate and coverage risk

“A decrease in reimbursement rates for our ASSURE WCD, or the introduction of other limitations to payors’ coverage for our ASSURE WCD, could adversely affect our results of operations and financial condition.” · word for word

Supply chain and manufacturing concentration

“We depend on a limited number of third-party suppliers and contract manufacturers to manufacture and recondition our ASSURE WCD and its components, which could make us vulnerable to supply shortages and price fluctuations that could harm our business.” · word for word

Macroeconomic and inflationary pressure

“Macroeconomic conditions, such as inflationary pressure, changes to monetary policy, fluctuations in interest rates ... can adversely impact demand for our products” · word for word

Operating expenses growing faster than revenue; adjusted EBITDA loss widening.

“GAAP operating expenses $47.7M vs $27.1M prior year; adjusted EBITDA loss $21.2M vs $16.3M.”

Continued Operating Losses

“We incurred net losses of $34.2 million and $21.8 million for the three months ended January 31, 2026 and 2025, respectively.” · word for word

Rapidly Growing SG&A Expenses

“Selling, general and administrative expenses for the three months ended January 31, 2026 increased by $18.9 million, or 79%, compared to the three months ended January 31, 2025.” · word for word

Dependence on Third-Party Payors

“We derive nearly all our revenue from the direct billing of various third-party payors, including Medicare, Medicaid, private payors and other healthcare-related organizations.” · word for word

GAAP net loss widening despite revenue growth; operating expenses increasing due to commercial expansion

“GAAP net loss and comprehensive loss was $32.8 million compared to $20.6 million in prior year period” · word for word

Continued operating losses and negative cash flow

“We incurred net losses of $32.8 million and $20.6 million for the three months ended October 31, 2025 and 2024, respectively.” · word for word

Dependence on third-party payor reimbursement

“We derive nearly all our revenue from the direct billing of various third-party payors, including Medicare, Medicaid, private payors and other healthcare-related organizations, for the lease of our ASSURE WCD to patients.” · word for word

Single product platform concentration

“We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of our Cardiac Recovery System platform is the ASSURE WCD.” · word for word

Seasonality from deductible resets

“Our billings and collections efforts during January and February tend to be lower because of resetting annual patient healthcare insurance plan deductibles.” · word for word

Dilution risk from new share issuance.

“Issuance of 6,900,000 common shares increases share count.”

Preliminary results subject to adjustment; company has history of net losses.

“These results are preliminary estimates and remain subject to adjustment. Risks related to limited operating history and history of net losses.” · word for word